News Sections
FDA Approves New Eli Lilly Diabetes Drug
Updated May 5, 2013 12:09 AM | Filed under: Network Indiana
 Print    Archive    RSS

(UNDATED) - The Food and Drug Administration has approved a diabetes drug created in a collaborative effort between Eli Lilly and Connecticut-based Boehringer Ingelheim Pharmaceuticals.

Tradjenta lowers blood sugar in a glucose-dependent manner by increasing incretin levels.

The drug is approved to be used by people with type 2 diabetes in conjunction with diet and exercise.

« Previous Article
Next Article »

 Print    Archive    RSS

Have a question or comment about a news story? Send it to

Advertise with 1340 AM WBIW
Advertise with 1340 AM WBIW

1340 AM WBIW, Bedford's Place To Talk. Serving Lawrence and surrounding counties since 1948!

© 2017 Ad-Venture Media, Inc. All Rights Reserved. and Listen Live Powered by HPC

Advertise  |  Careers  |  Contests  |  About  |  Feedback